EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Nestin and WT-1: Potential Interplay in Astrocytoma Tumor Biology

Asma Jalbani, Parisa Bashir, Prih Bashir, Javeria Tunio, Farah Siraj, Arpna Nihal

Advances in Modern Biomedicine · 2025

DOI: 10.63623/1ey3hk73 ↗
AbstractBibliografische Angaben

Abstract

Background: Glial cells are the origin of gliomas, a diverse group of brain tumors including Astrocytoma, Oligodendrogliomas and Ependymoma, classified based on their cellular origin. The St. Anne/Mayo grading system evaluates key histological features such as necrosis, endothelial proliferation, mitotic activity and cellular atypia to determine tumor grade and guide treatment. Although less common than other cancers, CNS malignancies cause significant morbidity and mortality, with thousands of new cases and deaths reported annually worldwide. Objective: The purpose of the current study was to examine the relationship between immunoexpression of the Nestin protein and WT-1 gene and various grades of Astrocytoma. Methods: A cross-sectional study was carried out at the Pathology Department of Basic Medical Science Institutes, Jinnah Postgraduate Medical College in Karachi, Sindh, Pakistan, from January 2019 to December 2022. There were 60 Astrocytoma cases in this investigation. All the cases of various grades of Astrocytoma were received in the department of Pathology, Basic Medical Sciences Institute, Jinnah Post Graduate Medical Center, Karachi were deeply reviewed and were included in this study. Results: Sixty examples of Astrocytoma were immunostained with WT-1 and Nestin. 86.7% of Astrocytoma cases had Nestin positivity, while 93.3% had positive WT-1 immunostaining. It was shown that there was a significant association (p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →